Allogeneic Stem Cells Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Merck, Teva Generics, Zhejiang Medicine, Zhejiang Aisheng Pharmaceutical, Besins Healthcare

The Allogeneic Stem Cells Market size was valued at US$ 689.90 million in 2021, and expected to increase to US$ 1.9 billion by 2027, at a CAGR of 11.2% from 2022 to 2027.

Allogeneic Stem Cells Market Overview

Allogeneic stem cells are most commonly connected with stem cell transplantation. In this procedure, a patient receives healthy blood-forming stem cells from a related donor who isn't their identical twin or from an unrelated donor who shares some of the patient's genetic makeup. Due to the expansion of genetic research for therapeutic and diagnostic purposes leveraging the therapeutic potency of stem cells, the market for allogeneic stem cells is expanding quickly on a global scale. By the end of 2017, 0.07 million batches of cord blood had been collected for public use, and even more had been collected for private usage, according to American Cancer Society, Inc. Therefore, the massive investment in stem cell research, development, and associated studies will fuel the market for allogeneic stem cells.

The market for allogeneic stem cells is being significantly driven by the rising prevalence of chronic diseases including cancer, cardiovascular diseases, etc. For instance, a forecast released by Globocan 2020 stated that there will be 19.2 million new cases of cancer worldwide by the year 2020, with chemotherapy being the most common form of treatment. Additionally, it has been found that chemotherapy's radiation can harm the patient's own stem cells, necessitating the transplantation of allogeneic stem cells. Additionally, according to data from HRSA Blood Stem Cell, the registry has about 23.1 million potential donors as of 2020. Thus, the allogeneic stem cell industry benefits from an increase in stem cell donors and the development of stem cell banking. However, some difficulties can occur after the transplantation, such as the patient's immune system misinterpreting the new stem cell as a foreign matter and stopping the engrafting process, which can be fatal. Additionally, the immune system of the donor may assault the patient's or recipient's healthy cells. Graft-versus-host disease is the medical term for this. The expensive expense of the procedure, in addition to these difficulties, is preventing the market for allogeneic stem cells from expanding throughout the anticipated era.

Industry News and Updates:

MARCH 07, 2022: Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S. --

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of a first generic version of Revlimid®1 (lenalidomide capsules), in 5mg, 10mg, 15mg, and 25mg strengths, in the United States. Teva’s Lenalidomide capsules are a prescription medicine used in adults for the treatment of (1) multiple myeloma in combination with the medicine dexamethasone, (2) certain myelodysplastic syndromes, and (3) mantle cell lymphoma following specific prior treatment. Please see the below “What are lenalidomide capsules?” section for more information.

What are the major Applications, Types and Regions for Allogeneic Stem Cells Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• Progesterone Oral


• Progesterone Injection


• Progesterone Suspended/Gel

By Application, it is segmented into

• Hospital


• Clinic


• Pharmacies & Drug Stores

Allogeneic Stem Cells Market Regional Analysis

North America dominated the allogeneic stem cell industry in 2020. Increased allogeneic hematopoietic cell transplantation in the area is to blame for the dominance. For instance, according to data from the HRSA Blood Stem Cell, 0.02 million HCTs were carried out in the United States in 2018, with 22.0 % of those being unrelated transplants and 19.0 % being related transplants. The market in Europe is anticipated to expand at a considerable CAGR due to the region's developed healthcare infrastructure and rising rates of myeloid, lymphoid, solid tumours, and non-malignant illnesses, which are driving up demand for both allogeneic and autologous stem cell transplants.

Asia Pacific is predicted to develop at a faster CAGR during the forecast period as a consequence of government financial support for healthcare advancement and an increasing number of patients suffering from cancer-related ailments, which will result in increased demand for stem cell transplantation. Due to the vast underserved market for the transplantation of stem cells, Latin America and the Middle East & Africa are predicted to experience a somewhat lower CAGR during the projected period.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Allogeneic Stem Cells Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Allogeneic Stem Cells Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Allogeneic Stem Cells Market report scope?

Key Takeaways from this Allogeneic Stem Cells Market Report

• Evaluate Allogeneic Stem Cells market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Allogeneic Stem Cells market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

Frequently Asked Questions

What is the growth rate of Allogeneic Stem Cells Market?

The Allogeneic Stem Cells Market is growing at a CAGR of 11.2% over the next 5 years.

Who are the key players in Allogeneic Stem Cells Market?

Merck, Teva Generics, Zhejiang Medicine, Zhejiang Aisheng Pharmaceutical, Besins Healthcare, Virtus Pharmaceuticals, BionPharma, CELGENE CORPORATION, Sangamo Therapeutics, MEDIPOST Co. Ltd., ANTEROGEN. CO. LTD., Vericel Corpoartion, Athersys, Inc., BrainStorm Cell Limited., Cellular Biomedicine Group, Catalent, Inc., Biosolution Co. Ltd., Cynata Therapeutics Ltd., JCR Pharmaceuticals Co. Ltd., Lineage Cell Therapeutics Inc., MiMedx Group Inc., Osiris Therapeutics Inc., Stempeutics Research Pvt. Ltd., Takeda Pharmaceutical Co. Ltd.

What are the significant types of Allogeneic Stem Cells Market?

Progesterone Oral, Progesterone Injection, Progesterone Suspended/Gel

What are the major end-use applications of Allogeneic Stem Cells Market?

Hospital, Clinic, Pharmacies & Drug Stores

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.